SM

Sanjay Mirikar

Director Director DIN 05349377
DIN 05349377 First appointment Mar 2012 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Mar 2012
Shareholding value •••• Premium profile

About Sanjay Mirikar

Data last updated:

Sanjay Mirikar was a Director at Canary Pharma Limited (2012–2019) and Director at Parul Finlease Private Limited (2012–2017). The companies operate in Pharma and Financial Services.

DIN 05349377
Primary Designation Director
Industry Pharma
First Appointment 12 Mar 2012

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Canary Pharma Limited U24232MP1995PLC008940
Director12 Mar 20121995₹4,850 (FY 2023)Converted To Llp
Parul Finlease Private Limited U65921MP1997PTC011924
Director17 Sep 20121997Converted To Llp

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Canary Pharma Limited
Parul Finlease Private Limited
Premium access

Shareholding and investment profile for Sanjay Mirikar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanjay Mirikar

Sanjay Mirikar was first appointed on 12 Mar 2012 as Director at Canary Pharma Limited.

Sanjay Mirikar held 2 earlier board appointments: Canary Pharma Limited (Director, 12 Mar 2012 to 05 Mar 2019); Parul Finlease Private Limited (Director, 17 Sep 2012 to 06 Apr 2017).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available